Form 4: Director O'Connor Acquires LMAT Shares via Vesting

Lemaitre Vascular Director John James O'Connor acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Summary

• Director John James O'Connor of Lemaitre Vascular Inc. (LMAT) acquired 5 shares of common stock on December 8, 2025.
• These shares were obtained through the release of dividend equivalent rights (DERs) on a one-for-one basis.
• The DERs were linked to the vesting of a restricted stock unit (RSU) award and a performance stock unit (PSU) award, both originally granted on December 8, 2023.
• Following these transactions, O'Connor directly beneficially owns 61,807 shares of common stock.
• O'Connor also holds 4.2075 and 3.8393 dividend equivalent rights related to other derivative securities.

Sentiment

Score: 6

Explanation: The transaction represents a routine vesting of equity awards, which is generally positive as it aligns management's interests with shareholders. No significant negative implications are present, and it's a standard compensation event.

Positives

• Director O'Connor increased his direct beneficial ownership of common stock by 5 shares, signaling continued alignment with shareholder interests.
• The vesting of restricted and performance stock units indicates the achievement of prior performance or service conditions, reflecting a standard compensation practice.

Future Outlook

This filing does not provide forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is an insider transaction report and does not provide broader industry context or trends. It reflects an individual director's equity compensation vesting, a common practice across industries to align management incentives with company performance.

Stakeholder Impact

• Shareholders: Increased director ownership, albeit minor, may signal confidence and better alignment of interests.
• Employees (specifically John James O'Connor): The vesting represents a realization of compensation for past performance or service, contributing to personal wealth.

Key Dates

Recommendation

This Form 4 reports a routine vesting of equity awards for a director, resulting in a minor increase in direct beneficial ownership. Such a transaction is a standard part of executive compensation and does not provide new fundamental information to warrant a change in investment recommendation. The company's overall financial health and strategic direction remain the primary drivers for investment decisions, which are not addressed in this filing.

Keywords

Lemaitre Vascular, LMAT, Form 4, Insider Transaction, Stock Acquisition, Restricted Stock Units, Performance Stock Units, Dividend Equivalent Rights, Director Ownership